Novo Nordisk on Track for Record High Close — Data Talk
Novo Nordisk A/S Sponsored ADR Class B (NVO) is currently at $143.47, up $0.59 or 0.41%
--Would be new all-time high (Based on available data back to April 30, 1981)
--Currently up eight consecutive days; up 8.13% over this period
--Longest winning streak since April 3, 2023, when it rose for eight straight trading days
--Best eight day stretch since the eight days ending May 15, 2024, when it rose 9.44%
--Up 6.05% month-to-date
--Up 38.69% year-to-date
--Up 80.75% from 52 weeks ago (June 12, 2023), when it closed at $79.38
--Would be a new 52-week closing high
--Up 88.47% from its 52-week closing low of $76.13 on July 11, 2023
--Traded as high as $143.62
--Up 0.52% at today's intraday high
All data as of 1:53:46 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 10, 2024 14:10 ET (18:10 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks